The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance : an AMR Insights global perspective

The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic’s potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic’s effect on global AMR.This study was supported by internal funding.https://academic.oup.com/jacamram2022School of Health Systems and Public Health (SHSPH

G protein Signaling, Journeys Beyond the Plasma Membrane

G proteins classically associated with the 7TM or serpentine receptors generally exist as a heterotrimeric complex consisting of alpha, beta and gamma subunits. These proteins serve as transducers of extracellular signal from plasma membrane to cellular interior. Binding of G protein-coupled receptor (GPCR) with a ligand leads to their activation, followed by that of G alpha, which then dissociates from G beta gamma subunits and initiate downstream effects through plasma membrane-localized effectors. This plasma membrane-restricted view of G proteins was challenged when they were found to be present in various intracellular locations such as endomembranes, cytoskeleton, mitochondria, and nucleus thereby opening up newer spatial domains for the action of these signaling molecules. Many recent studies have addressed the spatiotemporal dynamics underlying this atypical distribution and the G proteins have been shown to undergo activation-dependent as well as activation-independent relocalization. This spatially `directed' targeting of G proteins provides them rapid access to intracellular communication network without relying on diffusible second messengers. Here, we present a consolidated review of the existing knowledge about the presence and physiological roles for G proteins in these atypical locations, along with the mechanistic knowhow presently known about underlying processes

Looking for Solutions to the Pitfalls of Developing Novel Antibacterials in an Economically Challenging System

The increase in antibacterial resistance (ABR) currently equates in the minds of many with the distant fear that certain antibiotics will not work in 30 years on certain bacteria found in places the majority of us never go to. However, in reality, rising ABR already seriously threatens the effectiveness of compounds with which we treat common bacterial infections, which means that ABR is currently and will continue to undermine the foundations of modern medicine, including surgery and cancer treatment in hospitals, cities and countries across the world. That is why ABR is widely considered a global threat and one of the biggest problems of our current civilization. Conversely, antibiotic developments to market are few. Therefore, in this paper, we have illustrated the barriers to antimicrobial R&D the following questions and provided solutions to effective antimicrobial R&D